Pharmacokinetic Determinants of Drug Abuse and Dependence
about
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant usersRetrospective population cohort study on hip fracture risk associated with zolpidem medication.Is slow-onset long-acting monoamine transport blockade to cocaine as methadone is to heroin? Implication for anti-addiction medications.Increased vulnerability to cocaine in mice lacking dopamine D3 receptorsWake-promoting pharmacotherapy for psychiatric disorders.The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence.Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection.Clinical laboratory assessment of the abuse liability of an electronic cigarette.Behavioral mechanisms underlying nicotine reinforcement.A guide to benzodiazepine selection. Part II: Clinical aspects.Abuse, addiction, tolerance, and dependence to benzodiazepines in medical and nonmedical populations.T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.Benzodiazepines: tolerance, dependence, abuse, and addiction.Benzodiazepines revisited--will we ever learn?The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects.CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.The natural history of tolerance to the benzodiazepinesAttenuating the Agent: Reducing Opioid “Virulence”
P2860
Q28284151-DAE55E3C-1FEB-4379-8BD6-38F713E69793Q33708822-1DD8B41B-AAB9-4C7A-9312-932E1F21EB40Q34136977-E96F0418-ECFD-45B7-BFE0-B1D293EE047FQ34304643-575E6961-14FF-40DC-A218-4731BDACAC77Q34443394-EE29715B-6EBB-4BF6-80D3-000B06A4C253Q34612112-BF3DABE0-F764-4843-880F-0D4CDEE2D970Q34899113-AF33587A-64EA-446A-8A55-E7F67DA9A65FQ35899033-94FC4E3D-5242-4D17-960E-F08E6BC16248Q35954791-8E2AB715-FA2B-4493-AFBF-89B26DD2A923Q36495354-7EA0C698-83B9-4BA5-AAF7-0458E88B6DD5Q36495550-FCAF0F7D-3666-4510-8BFD-72717A96A769Q37310339-0283A516-B2BC-4E40-9716-9356A03AFFF7Q37584505-68F6B43E-46AD-434F-9DE4-5F65F5C4C24DQ37895716-DE15FB4C-7244-4C21-9B42-439BE1D73A74Q37983613-A23B2CC6-E874-48DC-92F4-D4770A0E5A1CQ41312831-EBA20177-6004-46EF-BCFD-F9B1F1F1E4C2Q46043227-C2731013-4385-4E75-AF68-59CE4711B5EDQ55891551-F0DD4D3F-F5A0-4560-9D21-6D897CC37B0BQ57462886-0800EA08-6A31-4359-82FE-DEF81AFC2FF6
P2860
Pharmacokinetic Determinants of Drug Abuse and Dependence
description
1986 nî lūn-bûn
@nan
1986 թուականին հրատարակուած գիտական յօդուած
@hyw
1986 թվականին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
name
Pharmacokinetic Determinants of Drug Abuse and Dependence
@ast
Pharmacokinetic Determinants of Drug Abuse and Dependence
@en
Pharmacokinetic Determinants of Drug Abuse and Dependence
@en-gb
Pharmacokinetic Determinants of Drug Abuse and Dependence
@nl
type
label
Pharmacokinetic Determinants of Drug Abuse and Dependence
@ast
Pharmacokinetic Determinants of Drug Abuse and Dependence
@en
Pharmacokinetic Determinants of Drug Abuse and Dependence
@en-gb
Pharmacokinetic Determinants of Drug Abuse and Dependence
@nl
altLabel
Pharmacokinetic determinants of drug abuse and dependence. A conceptual perspective
@en
prefLabel
Pharmacokinetic Determinants of Drug Abuse and Dependence
@ast
Pharmacokinetic Determinants of Drug Abuse and Dependence
@en
Pharmacokinetic Determinants of Drug Abuse and Dependence
@en-gb
Pharmacokinetic Determinants of Drug Abuse and Dependence
@nl
P1476
Pharmacokinetic Determinants of Drug Abuse and Dependence
@en
P2093
Edward M. Sellers
Usoa Busto
P304
P356
10.2165/00003088-198611020-00004
P407
P577
1986-01-01T00:00:00Z
P6179
1011911092